Physician profile
Scott Cluley
NPI 1568434157
$764.33
in general payments reported to CMS, 2019-2025
14 companies · $53.42 in 2025
The $53.42 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $158 · 2020: $128 · 2021: $51.23 · 2022: $221 · 2023: $33.61 · 2024: $120 · 2025: $53.42.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $207.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $206.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $132.23 | 2022-2024 | Closurefast |
| Artivion, INC. | $130.44 | 2020-2022 | |
| Biocompatibles, INC. | $125.36 | 2019 | |
| Boston Scientific Corporation | $90.12 | 2021-2025 | Varithena Administration Pack |
| Urgo Medical North America, LLC | $51.91 | 2024 | Urgok2, Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Drawtex Hydroconductive Wound Dressing With Levafiber 4x4 |
| Integra Lifesciences Corporation | $47.97 | 2020-2022 | |
| Misonix INC | $45.43 | 2020-2021 | |
| Janssen Pharmaceuticals, INC | $31.45 | 2019-2023 | Xarelto |
| Reprise Biomedical, INC. | $23.71 | 2025 | Miro3d |
| Organogenesis INC. | $22.47 | 2020 | |
| Angiodynamics, INC. | $17.95 | 2024 | Auryon Laser System 100-120 Vac |
| Smith+Nephew, INC. | $17.36 | 2019 | |
| Pfizer INC. | $17.00 | 2023 | |
| Cashflow Solutions, LLC | $10.93 | 2024 | Lympha Press Optimal Plus(US) Bt, Pcd-52 737a (US) White, Pcd-51 731a (US) - White |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Cluley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.